Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,31-0,21%
USD / PLN3,99-0,08%
CHF / PLN4,43+0,41%
GBP / PLN5,04+0,05%
EUR / USD1,08-0,13%
DAX18 501,15+0,13%
FT-SE7 959,96+0,35%
CAC 408 205,81+0,01%
DJI39 772,55+0,03%
S&P 5005 251,29+0,05%
ROPA BRENT86,59+1,04%
ROPA WTI82,80+1,32%
ZŁOTO2 220,73+1,32%
SREBRO24,85+1,14%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

KRKA: Closed proceedings against Krka Romania S.R.L. (2022-06-03 15:45)

ESPI | 17:45 03 czerwiec 2022
freepik.com
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop
POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No11/2022
Date of issue:2022-06-03
Short name of the issuer
KRKA
Subject
Closed proceedings against Krka Romania S.R.L.
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
According to the provisions of the Ljubljana Stock Exchange Rules and the applicable legislation, Krka, d. d., Novo mesto publishes as follows:

We hereby inform the interested public that the Romanian Anti-Corruption Directorate (Direcția Națională Anticorupție, DNA) has concluded the investigation of the alleged irregularities in conducting operations at Krka’s subsidiary, Krka Romania S.R.L.

Krka reported on alleged irregularities in its Romanian subsidiary in a public announcement of 17 January 2020, after the Romanian news portal the Libertatea was the first to publish about alleged irregularities. Following the news release, the Romanian DNA launched ex officio investigation of the alleged irregularities at Krka Romania S.R.L.

The investigation revealed that all promotional activities carried out by Krka Romania S.R.L. complied with the applicable legislation and good practice guidelines governing promotion of medicinal products in the EU and Romania. The DNA established no substantiated grounds for a suspected criminal offence by Krka Romania S.R.L. or its employees in marketing of medicinal products in Romania. DNA consequently closed the proceeding against Krka Romania S.R.L.

Krka has no knowledge of any appeal being lodged within the appeal term against the resolution passed by the DNA.


This notice is publicly available at the corporate web site www.krka.si from 3 June 2022 for the period of at least five (5) years.
Annexes
FileDescription
KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKAFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
8501Nove Mesto
(post code)(city)
Smarjeska6
(street)(number)
+386 7 331 21 11+386 7 332 15 37
(phone number)(fax)
(e-mail)(web site)
nie dotyczy
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2022-06-03Jože ColaričPresident of the Management Board and CEO

Masz ciekawy temat? Napisz do nas

Chcesz, żebyśmy opisali Twoją historię albo zajęli się jakimś problemem?

Masz ciekawy temat? Napisz do nas

Napisz do redakcji

Reklama

Czytaj dalej